Cited by 124Genetic Neurodegenerative DiseasesHereditary Neurological DisordersGenetic and rare skin diseases.

Expanding the Clinical Phenotype Associated With ELOVL4 Mutation: Study of a Large French-Canadian Family With Autosomal Dominant Spinocerebellar Ataxia and Erythrokeratodermia

Cadieux-Dion, Maxime, Turcotte-Gauthier, Maude, Noreau, Anne, Martin, Caroline, Meloche, Caroline, Gravel, Micheline, Drouin, Christian Allen, Rouleau, Guy A. +2 more·2014·JAMA Neurology

Abstract

IMPORTANCE: The autosomal dominant spinocerebellar ataxias (SCAs) are a complex group of neurodegenerative disorders with significant genetic heterogeneity. Despite the identification of 20 SCA genes, the cause of the disorder in a significant proportion of families with SCA remains unexplained. In 1972, a French-Canadian family segregating a combination of SCA and erythrokeratodermia variabilis (EKV) in an autosomal dominant fashion was described. OBJECTIVE: To map and identify the causative gene in this large family with SCA and EKV using a combination of linkage analysis and whole-exome sequencing. DESIGN, SETTING, AND PARTICIPANTS: A total of 32 individuals from the family have undergone complete neurologic and dermatologic examinations. MAIN OUTCOMES AND MEASURES: Mutations in ELOVL4 have been reported in families with macular degeneration. Recently, homozygous mutations were found in patients with ichthyosis, spastic paraplegia, and severe neurodevelopmental defects. In the present study, we report on a heterozygote mutation in ELOVL4 in affected individuals from the family with SCA and EKV. The mutation segregates with a milder phenotype consisting of early-onset patches of erythema and hyperkeratosis, as well as SCA manifesting in the fourth or fifth decade of life. RESULTS: We describe the mapping and the identification of a c.504G>C transversion in ELOVL4 resulting in the p.L168F substitution. We also provide clinical characterization of the phenotypes in 19 mutation carriers. CONCLUSIONS AND RELEVANCE: We report, to our knowledge, the first mutation in ELOVL4 that is associated with SCA and EKV. This gene encodes a member of the elongase family, which is responsible for the elongation of very long-chain fatty acids (at least 26 carbons). These fatty acids participate in a wide variety of physiological functions, including skin barrier formation and peroxisome β-oxidation. Overall, these results provide additional insight into the pathogenesis of these complex neurodegenerative disorders.

Integrity signals

Registry

Crossref · 10.1001/jamaneurol.2013.6337

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ELOVL4 mutations cause spinocerebellar ataxia, impaired neural development, neuronal dysfunction, hyper-excitability, seizures, juvenile macular degeneration in autosomal dominant STGD3, and early functional defects in RPE and PRCs.

    “ELOVL4 mutations cause spinocerebellar ataxia (Bourassa et al., 2015; Cadieux-Dion et al., 2014; Ozaki et al., 2015) impaired neural development, neuronal dysfunction, hyper-excitability, seizures (Agbaga, 2016; Aldahmesh et al., 2011) juvenile macular degeneration in autosomal dominant STGD3, with loss of central vision, progressive degeneration of the macula and peripheral retina (Agbaga et al.,”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cadieux-Dion, M., Turcotte-Gauthier, M., Noreau, A., Martin, C., Meloche, C., Gravel, M., Drouin, C. A., Rouleau, G. A., Nguyen, D. K., & Cossette, P.
Affiliations
  • Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Notre Dame Hospital, University of Montreal, Montreal, Quebec, Canada
  • Montreal Neurological Institute and Hospital (CA)
  • Hôpital Notre-Dame (CA)
  • Department of Dermatology, Grand Portage Hospital, Rivière du Loup, Quebec, Canada
Venue
JAMA Neurology
Published
2014-04-01
Volume
71
Issue
4
Pages
470
ISSN
2168-6149 (ISSN-L)
OpenAlex
W1990141561
Cited by
124
References
28
Citations by year
2026: 2 · 2025: 8 · 2024: 12 · 2023: 11 · 2022: 11 · 2021: 18 · 2020: 8 · 2019: 8 · 2018: 11 · 2017: 12 · 2016: 8 · 2015: 9 · 2014: 5
FWCI
5.16
Type
journal article
Language
en
Open access
closed
Locations
  • JAMA Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and rare skin diseases.
Keywords
ELOVL4, autosomal dominant spinocerebellar ataxia, erythrokeratodermia variabilis, heterozygous mutation, very long chain fatty acid elongation, genotype-phenotype correlation, clinical phenotype, linkage analysis, exome sequencing, skin barrier formation, neurodegenerative diseases
MeSH terms
Amino Acid Sequence, Eye Proteins, Female, Genetic Carrier Screening, Humans, Male, Membrane Proteins, Molecular Sequence Data, Pedigree, Phenotype, Quebec, Cohort Studies, Mutation, Missense, Spinocerebellar Ataxias, Erythrokeratodermia Variabilis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review